Read recent comments on drug cost issues.
Scientific American: Recent Supreme Court Ruling Will Help Sufferers
Days after the Supreme Court overturned Roe v. Wade, she made a much less publicized decision on prescription opioids, one much more welcome in the medical community. In a rare 9-0 decision in Ruan v. United States, the court ruled in favor of several doctors who were criminally convicted for acting as drug dealers by prescribing too many painkillers. (Maia Szalavitz, 09/19)
Modern healthcare: reducing out-of-pocket expenses
I hear every day from Wisconsin voters struggling to afford rising drug prices. Manitowoc’s Otis lives with diabetes, among other conditions that require prescription medication. (Sen. Tammy Baldwin (D-Wis.), 9/19)
Wall Street Journal: Hope for a new ALS treatment after all
Few diseases are as cruelly debilitating as amyotrophic lateral sclerosis (ALS). But a Food and Drug Administration advisory panel this week gave patients a glimmer of hope by backing a new treatment that can slow their decline and give them more time to live. (9/15)
The Baltimore Sun: Maryland pharmacies have proven their value as health centers
When the COVID-19 pandemic was at its peak and many doctors’ offices weren’t providing in-person visits for routine appointments, Marylanders were able to get their vaccination needs met at their pharmacy. local. Not only did this speed up the process for those who chose to get the COVID-19 vaccine, but thanks to the PREP law, families were also able to keep their children’s vaccines up to date at the pharmacy if they couldn’t. not enter with a pediatrician. (9/15)
Los Angeles Times: Prevent a legal trap that could push thousands of generic drugs off the market
Carvedilol could be the star child of drug price reduction. Since 2007, more than 20 million patients with cardiovascular disease have benefited from generic versions of the popular beta-blocker, which cost 2 cents a dose compared to $4.81 for the brand name product. Patents on the drug Coreg, dating from 1978, have long since expired, allowing these cost-effective generics. (Michael A. Carrier, Charles Duan, and S. Sean Tu, 9/21)
Los Angeles Times: Pharma’s Lack of Diversity Harms Women and People of Color
If you are a woman or a person of color, your health suffers from the lack of diversity in health care. I suddenly realized this a few years ago at a conference for pharmaceutical industry executives. (Lindsay Androski, 9/15)
New England Journal of Medicine: Pushing back the pills – Improving access to reproductive health drugs after Dobbs
The June 24, 2022 United States Supreme Court decision in Dobbs v. Jackson Women’s Health Organization, which overturned Roe v. Wade, underscored the increasingly critical role that drugs (and therefore drug regulation) will play in the future of reproductive rights. (Lewis A. Grossman, JD, Ph.D., 9/17)
This is part of the KHN Morning Briefing, a summary of health policy coverage from major news outlets. Sign up for an email subscription.